|Project Title||Brookings Roundtable on Active Medical Product Surveillance: Overview of FDA’s Sentinel Initiative|
Tuesday, September 6, 2011
On September 7, the Engelberg Center hosted the first of the three-part Sentinel Initiative 101 Webinar Series, “Overview of FDA’s Sentinel Initiative” to review ongoing activities and accomplishments. The roundtable featured a presentation from Dr. Judy Racoosin, Sentinel Initiative Scientific Lead, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
Dr. Racoosin’s presentation provided a high-level review of the Sentinel Initiative’s scope and achievements including:
Mark McClellan MD, PhD, MPA; Engelberg Center for Health Care Reform, Brookings Institution, Washington, DC
Judy Racoosin MD, MPH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Springs, MD